EnBrace HR/MF Product Information


EnBrace HR/MF is a medical food to be used under medical supervision that has been specifically formulated for patients with methylenetetrahydrofolate reductase (MTHFR) genotypes and/or other B-Vitamin polymorphisms or folate deficiency that may contribute to hyperhomocysteinemia.

EnBrace HR/MF provides patients special, medically-determined nutrient requirements including L-Methylfolate, Omega 3's, and other B vitamin coenzymes and mineral co-factors in amounts that cannot be achieved by the modification of the normal diet alone.

INGREDIENTS
Each softgel contains the following ingredients:

L-Methylfolate......................................................7mg

Folinic Acid...........................................................2.2mg

Citrate Folic Acid................................................1mg

Phospholipid-Omega3s.....................................20mg

Ferrous Glycinate Cysteinate...........................12.5mg

Magnesium Ascorbate.......................................24mg

Zinc Ascorbate....................................................1mg

L-Threonic Acid Magnesium.............................1mg

Vitamin B1 Thiamine Pyrophosphate..............25mcg

Vitamin B2 FAD...................................................25mcg

Vitamin B3 NADH...............................................25mcg

Vitamin B6 Pyridoxal 5’ Phosphate.................25mcg

Vitamin B12 Adenosylcobalamin.....................25mcg

Vitamin B12 Methylcobalamin.........................25mcg

EnBrace HR/MF DOES NOT contain artificial dyes, artificial flavors/sweeteners and gluten.  EnBrace HR/MF is third-party certified gluten-free and contains less than 5000ppm alcohol. 

INDICATIONS AND USAGE:

EnBrace HR/MF is indicated for patients with distinct nutritional requirements for the dietary management of certain metabolic processes identified with hyperhomocysteinemia that contribute to major depressive disorder, pain, tingling, and sensation related to diabetic peripheral neuropathy; dementia, cognitive dysfunction, and Alzheimer’s disease; addiction and/or abuse abatement; early and end-stage renal disease; migraine with or without aura; ADHD and age-related macular degeneration.